Madrigal Pharmaceuticals

MDGL

Insider trades and stock quote 2024-2026

All insider trades at Madrigal Pharmaceuticals

Subscribe RSS
Date Type Insider Position Ø-Price Volume
7/20/2026 Sell Sibold, William John President and CEO $547.6 $1,368,253
6/1/2026 Sell Soergel, David Chief Medical Officer $495.7 $516,561
5/22/2026 Sell Levy, Richard S. Director $513.8 $2,928,716
5/18/2026 Sell Soergel, David Chief Medical Officer $515.9 $435,420
3/6/2026 Sell Taub, Rebecca Director $431.9 $212,083
3/6/2026 Sell Huntsman, Carole Chief Commercial Officer $431.9 $180,983
3/6/2026 Sell Kelley, Shannon T. General Counsel $431.9 $155,498
3/6/2026 Sell Sibold, William John President and CEO $431.9 $718,316
3/6/2026 Sell Dier, Mardi EVP and CFO $431.5 $853,991
3/2/2026 Sell Dier, Mardi EVP and CFO $427.2 $505,389
1/26/2026 Sell Taub, Rebecca Director $492.4 $318,596
1/26/2026 Sell Sibold, William John President and CEO $492.4 $776,546
1/26/2026 Sell Huntsman, Carole Chief Commercial Officer $493.5 $449,339
1/20/2026 Sell Taub, Rebecca Director $490.8 $1,098,343
1/20/2026 Sell Kelley, Shannon T. General Counsel $496.1 $344,174
1/9/2026 Sell Taub, Rebecca Director $528.2 $9,749,392
1/9/2026 Sell Friedman, Paul A. Director $527.7 $12,963,306
12/10/2025 Sell Taub, Rebecca Director $551.8 $10,297,573
12/10/2025 Sell Friedman, Paul A. Director $551.8 $13,694,158
12/4/2025 Sell Sibold, William John President and CEO $575.3 $1,380,816
12/2/2025 Sell Dier, Mardi EVP and CFO $581.4 $2,413,417
11/21/2025 Sell Huntsman, Carole Chief Commercial Officer $555.1 $1,082,987
11/13/2025 Sell Levy, Richard S. Director $522.3 $4,428,197
11/5/2025 Sell Bate, Kenneth Director $485.6 $8,027,354
9/9/2025 Sell Sibold, William John President and CEO $445.6 $3,243,741
8/21/2025 Sell Sibold, William John President and CEO $400.5 $3,047,756
8/20/2025 Buy Baker Bros. Advisors Lp Director $385.0 $23,071,366
8/18/2025 Buy Baker Bros. Advisors Lp Director $364.6 $38,849,660
8/18/2025 Sell Kelley, Shannon T. General Counsel $371.1 $479,626
8/15/2025 Sell Bate, Kenneth Director $365.9 $3,652,009
8/13/2025 Sell Friedman, Paul A. Director $366.3 $47,825,151
8/12/2025 Sell Friedman, Paul A. Director $355.4 $15,509,469
8/12/2025 Sell Taub, Rebecca Director $355.3 $15,388,278
8/11/2025 Sell Friedman, Paul A. Director $350.6 $1,121,917
8/11/2025 Sell Taub, Rebecca Director $350.6 $1,120,753
7/18/2025 Sell Friedman, Paul A. Director $350.0 $490,044
7/18/2025 Sell Taub, Rebecca Director $350.0 $350,005
7/17/2025 Sell Taub, Rebecca Director $350.8 $931,035
7/17/2025 Sell Friedman, Paul A. Director $350.8 $946,301
7/16/2025 Sell Taub, Rebecca Director $353.5 $9,347,062
7/16/2025 Sell Friedman, Paul A. Director $353.6 $9,252,544
3/13/2025 Sell Craves, Fred B. Director $326.6 $2,518,054
3/12/2025 Sell Craves, Fred B. Director $332.6 $2,564,427
3/10/2025 Sell Dier, Mardi SVP and CFO $323.0 $83,344
3/5/2025 Sell Waltermire, Robert E. Senior VP, Chief Pharma Dev. $340.4 $4,817,104
3/3/2025 Sell Huntsman, Carole Chief Commercial Officer $323.9 $597,840
3/3/2025 Sell Dier, Mardi SVP and CFO $324.7 $637,248
3/3/2025 Sell Kelley, Shannon T. General Counsel $335.0 $139,025
2/28/2025 Sell Waltermire, Robert E. Senior VP, Chief Pharma Dev. $341.3 $418,488
2/27/2025 Sell Bate, Kenneth Director $355.9 $7,128,759
2/27/2025 Sell Daly, James M. Director $347.8 $5,375,125
1/24/2025 Sell Waltermire, Robert E. Senior VP, Chief Pharma Dev. $335.2 $34,530
1/24/2025 Sell Taub, Rebecca Pres., R&D, and CMO $335.2 $217,236
1/24/2025 Sell Sibold, William John President and CEO $335.2 $531,020
1/24/2025 Sell Huntsman, Carole Chief Commercial Officer $335.2 $116,328
1/17/2025 Sell Taub, Rebecca Pres., R&D, and CMO $273.4 $461,789
1/17/2025 Sell Waltermire, Robert E. Senior VP, Chief Pharma Dev. $273.4 $120,847
1/17/2025 Sell Kelley, Shannon T. General Counsel $273.4 $75,735
12/3/2024 Sell Craves, Fred B. Director $315.6 $1,135,122
11/25/2024 Sell Craves, Fred B. Director $350.4 $1,191,029
11/21/2024 Sell Huntsman, Carole Chief Commercial Officer $316.9 $218,041
11/7/2024 Sell Levy, Richard S. Director $350.0 $1,750,000
11/1/2024 Sell Levy, Richard S. Director $302.0 $1,504,703
9/9/2024 Sell Sibold, William John President and CEO $243.8 $1,551,490
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)